Some factors that could trigger social apnea include irregular sleep schedules, alcohol, smoking, and other weekend-related ...

An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week 72, orforglipron at multiple ...

The first hints that Gregory Nelson might be having cognitive troubles were subtle. “Everyone who hits a certain age just ...

Novo Nordisk , looking to turn around slowing growth of its blockbuster weight-loss drug Wegovy, plans to test whether its ...

Novo Nordisk is planning clinical trials to explore the potential of its weight-loss drugs in treating obesity-related conditions.

The fundamentals of the industry are driven by demographics, and broadening the scope provides a bit of growth opportunity,' ...

Novo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, ...

The Apple Watch SE 3 delivers two-day battery life, a top-of-the-line processor, an always-on display, and upgraded sensors ...

ONCE again, Apple has pulled a blinder with its most premium smartwatch model. The Apple Watch Ultra 3 is the new reigning champ – and I’ve been trying it out for just under a week. Apple ...

STORY: Novo Nordisk will test whether its future weight-loss drugs can treat a wide range of obesity-linked conditions. It’s ...